Distinctiveness of secretory phospholipase A2 group IIA and V suggesting unique roles in atherosclerosis.

Rosengren, Birgitta; Jönsson-Rylander, Ann-Cathrine; Peilot, Helena; Camejo, German; Hurt-Camejo, Eva

Rosengren, Birgitta; Jönsson-Rylander, Ann-Cathrine; Peilot, Helena; Camejo, German; Hurt-Camejo, Eva.

Affiliation

Rosengren B; AstraZeneca, R&D, Molecular Pharmacology, Mölndal S-431 83, Sweden.

Biochim Biophys Acta ; 1761(11): 1301-8, 2006 Nov.

Article in En | MEDLINE | ID: mdl-17070102

Subject(s)

Coronary Artery Disease/enzymology; Gene Expression Regulation, Enzymologic; Lipoproteins/metabolism; Phospholipases A/metabolism; Up-Regulation; Acute Disease; Animals; Coronary Artery Disease/pathology; Group II Phospholipases A2; Group V Phospholipases A2; Humans; Hyperlipidemias/enzymology; Hyperlipidemias/pathology; Inflammation/enzymology; Inflammation/pathology; Phospholipases A2; Proteoglycans/metabolism; Tunica Intima/enzymology; Tunica Intima/pathology

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Phospholipases A / Coronary Artery Disease / Gene Expression Regulation, Enzymologic / Up-Regulation / Lipoproteins Limits: Animals / Humans Language: En Journal: Biochim Biophys Acta Year: 2006 Type: Article Affiliation country: Sweden

Search on Google

Add to My VHL

XML

PubMed Links